Idarubicina
Idarubicina Uses, Dosage, Side Effects, Mechanism of Action, How Long Does it Take to Work? Idarubicina is a brand name. Its generic name is Idarubicin.
Introduction
Idarubicina, also known as IDA, is a chemotherapeutic drug prepared from a naturally occurring anthracycline antibiotic, daunorubicin. IDA is used worldwide to treat patients with acute myelogenous leukemia (AML). Idarubicina is used as the standard for induction therapy among AML patients.Uses for
Idarubicina is used to treat acute myelogenous leukemia (AML) in adult and pediatric patients. It is also used in combination with other drugs to treat multiple myeloma.Mechanism of Action
Idarubicina interferes with DNA and RNA synthesis, causing the destruction of cancer cells. It works by blocking the enzymes necessary for tumor cell replication and growth.How Long Does It Take to Work?
The effects of Idarubicina can usually be seen within 1-2 weeks of treatment. It may take up to 6 months for your symptoms to completely resolve.Absorption
Idarubicina is minimally absorbed from the gastrointestinal tract. The oral bioavailability of IDA is extremely low (less than 1%), meaning that it must be given intravenously to be effective.Route of Elimination
Idarubicina is metabolized in the liver and then eliminated in the urine and feces.Dosage
Idarubicina should be administered intravenously in doses of 10 to 12 mg/m² of body surface area, over 1 to 4 hours. The dosage may be increased or decreased depending on the patient's individual response and the severity of side effects.Administration
Idarubicina must be administered as an intravenous injection or infusion directly into a vein. The infusion solution should be free from particulate matter and other contaminants.Side Effects
Common side effects of Idarubicina include nausea, vomiting, diarrhea, rash, fatigue, headache, hair loss, and pain at the injection site. Other less common side effects may include anemia, depression, confusion, and changes in blood pressure.Toxicity
Idarubicina is an antineoplastic and is toxic in humans. Accidental or intentional ingestion of Idarubicina may cause severe nausea, vomiting, abdominal pain, and confusion.Precautions
Idarubicina should be used with caution in patients with a history of liver or kidney disease, heart disease, or low white blood cell count.Interactions
Idarubicina may interact with other drugs and dietary supplements. It is important to tell your doctor about any medications or supplements you are taking before starting treatment with Idarubicina.Disease Interaction
Idarubicina may interact with certain diseases, such as bone marrow depression or clotting disorders. It is important to tell your doctor about any illnesses or diseases you are suffering from before taking Idarubicina.Drug Interactions
Idarubicina may interact with other medications. Before starting treatment with Idarubicina, it is important to tell your doctor about any medications or supplements you are taking.Food Interactions
Idarubicina may interact with certain foods or beverages. It is important to discuss your diet with your doctor before starting treatment with Idarubicina.Pregnancy Use
Idarubicina is not recommended for use during pregnancy. It is important to discuss the risks and benefits of treatment with your doctor.Lactation Use
It is not known if Idarubicina passes into breast milk. The use of Idarubicina during lactation is not recommended.Acute Overdose
An overdose of Idarubicina can cause nausea, vomiting, diarrhea, abdominal pain, anemia, confusion, and coma. Seek emergency medical attention if an overdose is suspected.Contraindications
Idarubicina should not be used in patients with a known or suspected hypersensitivity to it or any of its components. It is also contraindicated in patients with severe bone marrow depression or clotting disorders.Use Direction
Idarubicina should be administered intravenously according to your doctor's instructions. Carefully follow your doctor's prescribed dosage and administration schedule.Storage Conditions
Idarubicina is stored in an inert gas atmosphere at room temperature. It should not be frozen and should be protected from light.Volume of Distribution
The volume of distribution of Idarubicina is 0.5-1 liter/kg.Half-Life
The half-life of Idarubicina is 3-4 hours.Clearance
The clearance of Idarubicina is 0.3-0.7 liters/hr/kg.Here you find in details version of Idarubicina
Some Frequently Asked Questions About Idarubicina
https://www.medicinesfaq.com/brand/idarubicina,
,
,
https://www.ebi.ac.uk/chebi/searchId.do?chebiId=CHEBI:42068,
http://www.hmdb.ca/metabolites/HMDB0015308,
https://pubchem.ncbi.nlm.nih.gov/summary/summary.cgi?cid=42890,
https://pubchem.ncbi.nlm.nih.gov/summary/summary.cgi?sid=46506973,
https://www.chemspider.com/Chemical-Structure.39117.html,
http://www.bindingdb.org/bind/chemsearch/marvin/MolStructure.jsp?monomerid=58490,
https://mor.nlm.nih.gov/RxNav/search?searchBy=RXCUI&searchTerm=5650,
https://www.ebi.ac.uk/chebi/searchId.do?chebiId=42068,
https://www.ebi.ac.uk/chembldb/index.php/compound/inspect/CHEMBL1117,
https://zinc.docking.org/substances/ZINC000003920266,
http://bidd.nus.edu.sg/group/cjttd/ZFTTDDRUG.asp?ID=DAP000050,
http://www.pharmgkb.org/drug/PA449961,
https://www.ebi.ac.uk/pdbe-srv/pdbechem/chemicalCompound/show/DM5,
http://www.rxlist.com/cgi/generic2/idarubicin.htm,
https://www.drugs.com/cdi/idarubicin.html,
https://en.wikipedia.org/wiki/Idarubicin,